JW (Cayman) Therapeutics Co Ltd
HKEX:2126
JW (Cayman) Therapeutics Co Ltd
Other Equity
JW (Cayman) Therapeutics Co Ltd
Other Equity Peer Comparison
Competitive Other Equity Analysis
Latest Figures & CAGR of Competitors
Company | Other Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
JW (Cayman) Therapeutics Co Ltd
HKEX:2126
|
Other Equity
-¥189.9m
|
CAGR 3-Years
-21%
|
CAGR 5-Years
-68%
|
CAGR 10-Years
N/A
|
|
Beigene Ltd
HKEX:6160
|
Other Equity
¥1.4B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
28%
|
CAGR 10-Years
N/A
|
|
Innovent Biologics Inc
HKEX:1801
|
Other Equity
-¥20.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
|
Other Equity
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
|
Other Equity
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Imeik Technology Development Co Ltd
SZSE:300896
|
Other Equity
¥2.8m
|
CAGR 3-Years
-60%
|
CAGR 5-Years
-27%
|
CAGR 10-Years
N/A
|
See Also
What is JW (Cayman) Therapeutics Co Ltd's Other Equity?
Other Equity
-189.9m
CNY
Based on the financial report for Dec 31, 2023, JW (Cayman) Therapeutics Co Ltd's Other Equity amounts to -189.9m CNY.
What is JW (Cayman) Therapeutics Co Ltd's Other Equity growth rate?
Other Equity CAGR 5Y
-68%
Over the last year, the Other Equity growth was 0%. The average annual Other Equity growth rates for JW (Cayman) Therapeutics Co Ltd have been -21% over the past three years , -68% over the past five years .